According to the original drawing of D. F. Gleason,

Similar documents
Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance

ARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY. Jonathan I. Epstein.

OMPRN Pathology Matters Meeting 2017

Although current American Cancer Society guidelines

The Role of the Pathologist Active Surveillance for Prostate Cancer

ACCME/Disclosures. Cribriform Lesions of the Prostate. Case

Gleason Scoring System 2017 JASREMAN DHILLON, MD ASSOCIATE PROFESSOR, DEPARTMENT OF ANATOMIC PATHOLOGY, MOFFITT CANCER CENTER, TAMPA, FLORIDA

Division of Oncology, S Orsola-Malpighi Hospital, Bologna, Italy. Department of Surgery, Cordoba University Medical School, Cordoba, Spain

2016 WHO CLASSIFICATION OF TUMOURS OF THE PROSTATE. Peter A. Humphrey, MD, PhD Yale University School of Medicine New Haven, CT

In 2005, International Society of Urological Pathology

INTRADUCTAL LESIONS OF THE PROSTATE. Jonathan I. Epstein

Supplemental Information

Prostatic ductal adenocarcinoma is a subtype of

3/23/2017. Significant Changes in Prostate Cancer Classification, Grading, Staging and Reporting. Disclosure of Relevant Financial Relationships

Percent Gleason pattern 4 in stratifying the prognosis of patients with intermediate-risk prostate cancer

Procedures Needle Biopsy Transurethral Prostatic Resection Suprapubic or Retropubic Enucleation (Subtotal Prostatectomy) Radical Prostatectomy

Pathology of the Prostate. PathoBasic Tatjana Vlajnic

PSA. HMCK, p63, Racemase. HMCK, p63, Racemase

Chronic inflammation of long-standing duration has

Clinicopathological Features of Prostate Ductal Carcinoma: Matching Analysis and Comparison with Prostate Acinar Carcinoma

Diagnosis, pathology and prognosis including variant pathology

EUROPEAN UROLOGY 58 (2010)

Interobserver reproducibility of modified Gleason score in radical prostatectomy specimens

Intraductal Carcinoma of the Prostate

Recommendations for the Reporting of Prostate Carcinoma

Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017

Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma

Review Article Recent advances in prostate cancer pathology: Gleason grading and beyond

3/28/2017. Disclosure of Relevant Financial Relationships. GU Evening Subspecialty Case Conference. Differential Diagnosis:

Introduction. Key Words: high-grade prostatic intraepithelial neoplasia, HGPIN, radical prostatectomy, prostate biopsy, insignificant prostate cancer

Ductal adenocarcinoma of the prostate: A clinicopathological study

Prostatic ductal adenocarcinoma: An aggressive variant that is underdiagnosed and undersampled on transrectal ultrasound (TRUS)-guided needle biopsy

Protocol for the Examination of Biopsy Specimens From Patients With Carcinoma of the Prostate Gland

Protocol for the Examination of TURP Specimens From Patients With Carcinoma of the Prostate Gland

Donald F. Gleason in 1966 created a unique grading system

Hyperplastic, Premalignant and Malignant Lesions of the Prostate Gland

Percentage of Gleason Pattern 4 and 5 Predicts Survival After Radical Prostatectomy

Features and Prognostic Significance of Intraductal Carcinoma of the Prostate

Received: 11 Feb. 2013; Accepted: 7 Jun. 2013

Update on Reporting Prostate Cancer Pathology

Grading Prostate Cancer: Recent Changes and Refinements

Disease-specific death and metastasis do not occur in patients with Gleason score 6 at radical prostatectomy

Establishing a definitive pathologic diagnosis in surgical

S1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles

Prostate Cancer Grading, Staging and Reporting: An Update Cristina Magi-Galluzzi, MD, PhD

MORPHOLOGIC TRANSITIONS BETWEEN PROLIFERATIVE INFLAMMATORY ATROPHY AND HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA

Gleason grading and prognostic factors in carcinoma of the prostate

ASSESSMENT OF GLEASON SYSTEM USE ON DIFFERENT TYPES OF PROSTATIC TISSUE SAMPLES

Accepted Article. Received Date : 04-Dec-2015 Revised Date : 17-Mar-2016 Accepted Date : 27-Mar-2016 Article type : Original Article TITLE PAGE

Internationally indexed journal

ROLE OF PROSTATIC BASAL CELL MARKER IN DIAGNOSIS OF PROSTATIC LESIONS

On cribriform prostate cancer

Anatomic distribution and pathologic characterization of small-volume prostate cancer (o0.5 ml) in whole-mount prostatectomy specimens

Prostate cancer grading: a decade after the 2005 modified system

Prognostic value of the Gleason score in prostate cancer

A re-audit of Prostate biopsies from January to December 2010 and 2013.

Inverted (hobnail) high grade prostatic intraepithelial neoplasia and invasive inverted pattern

Invasion of the muscular wall of the seminal vesicles by prostate cancer is generally

ISPUB.COM. Interpretation Of Prostatic Biopsies: A Review. A Chitale, S Khubchandani INTRODUCTION NON-NEOPLASTIC LESIONS GRADING: GLEASON'S SCORE

Patient identifiers Date of request Accession/Laboratory number. CLINICAL STAGE (Note 3)

Although partial atrophy is one of the most common

Are Prostate Carcinoma Clinical Stages T1c and T2 Similar?

Diagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018

The importance of histopathologic review of biopsies in patients with prostate cancer referred to a tertiary uro - oncology center

Original Article Collagenous micronodules in prostate cancer revisited: are they solely associated with Gleason pattern 3 adenocarcinomas?

University of Zagreb Medical School Repository

Radical prostatectomy is the most widely used treatment. Partial Sampling of Radical Prostatectomy Specimens

Study of High Grade Prostatic Intraepithelial Neoplasia for a Period of Five Years B. Rajashekar Reddy 1, Rameswarapu Suman Babu 2 and P.

PROGNOSTIC ROLE OF NEW CONTEMPORARY GRADING SYSTEM IN PROSTATE CANCER

PROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA AND IMPORTANT MIMICKERS PROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA

Mucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging entity

Epithelial Columnar Breast Lesions: Histopathology and Molecular Markers

Prostate Pathology: Prostate Carcinoma, variants and Gleason Grading (Part 1)

Large blocks in prostate and bladder pathology

Urinary Bladder, Ureter, and Renal Pelvis

P504S Immunostaining Boosts Diagnostic Resolution of Suspicious Foci in Prostatic Needle Biopsy Specimens

Correlation between Gleason Scores in Needle Biopsy and Corresponding Radical Prostatectomy Specimens: A Twelve-Year Review

Crystalloids of Prostatic Adenocarcinoma on Prostatectomy

Patient identifiers Date of request Accession/Laboratory number FOR EACH SPECIMEN - COMPLETE THE FOLLOWING:

Prostate lesions with cribriform / pseudocribriform pattern

IRANIAN MEDICINE. Original Article

Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of

Int J Clin Exp Pathol 2014;7(2): /ISSN: /IJCEP

Prostate cancer volume estimations based on transrectal ultrasonography-guided biopsy in order to predict clinically significant prostate cancer

OPEN ACCESS ORIGINAL ARTICLE

Clinicopathological Spectrum of Prostatic Adenocarcinoma in 60 Patients

Review by urological pathologists improves the accuracy of Gleason grading by general pathologists

EARLY ONLINE RELEASE

CK20 and p53 Immunohistochemical Staining Patterns in Urinary Bladder Specimens With Equivocal Atypia. Correlation With Outcomes

The International Society of Urological Pathology Companion Meeting

Diagnostic Uncertainty Expressed in Prostate Needle Biopsies

Original Article INTRODUCTION. Abstract

Owing to the widespread use of prostate specific antigen (PSA)

Outline (1) Outline (2) Concepts in Prostate Pathology. Peculiarities of Prostate Cancer. Peculiarities of Prostate Cancer

Pathologic Results of Radical Prostatectomies in Patients with Simultaneous Atypical Small Acinar Proliferation and Prostate Cancer

Prostate Case Scenario 1

Since the beginning of the prostate-specific antigen (PSA) era in the. Characteristics of Insignificant Clinical T1c Prostate Tumors

High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy

Department of Diagnostic Pathology, Kochi Red Cross Hospital, Kochi, Japan

Significance of Atypical Small Acinar Proliferation and High-Grade Prostatic Intraepithelial Neoplasia in Prostate Biopsy

Transcription:

ORIGINAL ARTICLE Grading of Invasive Cribriform Carcinoma on Prostate Needle Biopsy An Interobserver Study among Experts in Genitourinary Pathology Mathieu Latour, MD,* Mahul B. Amin, MD,y Athanase Billis MD,J Lars Egevad MD, PhD,z David J. Grignon, MD,# Peter A. Humphrey, MD, PhD, ** Victor E. Reuter, MD, ww Wael A. Sakr, MD, zz John R. Srigley MD, yy Thomas M. Wheeler, MD,JJ Ximing J. Yang, MD, PhD,zz and Jonathan I. Epstein, MD*w z Abstract: The distinction between cribriform Gleason pattern 3 and 4 prostate cancer is controversial. Out of 3590 prostate cancers sent to one of the authors over 7 months, 30 needle biopsy cases were selected that possibly represented cribriform Gleason pattern 3 cancer. Thirty-six digital images were taken and sent to 10 experts in prostate pathology. Consensus was defined when at least 7/10 experts agreed on the grade. Sixtyseven percent (n = 24) of images reached consensus (23 pattern 4; 1 pattern 3). Of the 12 nonconsensus images, 7 were favor pattern 4 (6/10 experts agreed), 1 was favor pattern 3 (6/10 experts agreed), and 4 were equivocal (<6 experts agreed). The most common criteria used to call pattern 4 in the 23 consensus pattern 4 images were in frequency: irregular contour, irregular distribution of lumens, slit-like lumens, large glands, number of glands, and small lumens. In the only consensus pattern 3 image, criteria used were regular contour, small glands, regular distribution of lumens, and uniform round lumens. Discrepancy between experts was qualified as primarily objective (different criteria present) in 38%, subjective (different interpretation of the same criteria) in 12%, and mixed (both objective and subjective) in 50%. The most frequent situation with different interpretations of the same criteria were regular versus irregular contour and small versus large glands, with the former more common. Even in this highly selected set of images thought to be the best candidates for cribriform pattern 3 from a busy consult From the Departments of *Pathology; wurology; zoncology, The Johns Hopkins Hospital, Baltimore, MD; ydepartment of Pathology, Cedars Sinai Medical Center, Los Angeles, CA; JDepartment of Anatomic Pathology, State University of Campinas (Unicamp) School of Medicine, Campinas, São Paulo, Brazil; ziarc/who, Lyon, France; #Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN; **Division of Anatomic Pathology, Washington University School of Medicine, St Louis, MO; wwdepartment of Pathology, MSKCC, New York, NY; zzanatomic Pathology, Wayne State University, Detroit, MI; yydepartment of Laboratory Medicine, Credit Valley Hospital, Mississauga, Canada; JJDepartment of Pathology, Baylor College of Medicine, Houston, TX; and zzdepartment of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL. Correspondence: Jonathan I. Epstein, MD, Department of Pathology, The Johns Hopkins Hospital, The Weinberg Building, Rm. 2242 401 N. Broadway Street Baltimore, MD 21231 (e-mail: jepstein@jhmi.edu). Copyright r 2008 by Lippincott Williams & Wilkins service, most experts interpreted the cribriform patterns as pattern 4. Moreover, most of the cribriform foci investigated (73%) were associated with more definitive pattern 4 elsewhere on the needle biopsy specimen. In conclusion, most of the small cribriform cancer foci seen on needle biopsy should be interpreted as Gleason pattern 4 and not pattern 3. Key Words: cribriform, carcinoma of the prostate, prostate needle biopsy, Gleason grading (Am J Surg Pathol 2008;32:1532 1539) According to the original drawing of D. F. Gleason, cribriform cancer was included in patterns 2, 3, 4, and 5. 2,9,10 The original Gleason system did not describe the differences between the various cribriform patterns beyond the schematic diagram. Even with the revision of the Gleason system at an International Society of Urological Pathology (ISUP) consensus conference, the distinction between Gleason cribriform pattern 3 and 4 was still not resolved in terms of its practical application. 7,8,12 It is currently unknown how most experts in prostate pathology would apply criteria to assign a grade on a relatively small focus of cribriform carcinoma on needle biopsy, which is not an obvious pattern 4. MATERIALS AND METHODS Out of 3590 prostate cancers sent to one of the authors (J.I.E.) in consultation over a period of 7 months (December 14, 2006 to July 2, 2007), 30 prostate needle biopsy cases were prospectively selected that possibly contained foci of cribriform Gleason pattern 3 cancer. The surrounding cancer grade on the same core and on other cores were noted by one of the authors (J.I.E.) for each biopsy according to the modified Gleason grading system. 8 A digital file made of 36 static images taken from the selected needle biopsies was sent to a group of 10 experts in prostate pathology (M.B.A., A.B., L.E., D.J.G., P.A.H., V.E.R., W.A.S., J.R.S., T.M.W., and X.J.Y.) A questionnaire was attached to the digital file and respondents had to answer for each image which 1532 Am J Surg Pathol Volume 32, Number 10, October 2008

Am J Surg Pathol Volume 32, Number 10, October 2008 Grading of Invasive Cribriform Carcinoma TABLE 1. Histologic Criteria Used by Experts to Separate Cribriform Gleason Pattern 3 From Gleason Pattern 4 Gleason Pattern 3 Gleason Pattern 4 Small glands Large glands Regular contour Irregular contour/jagged edges Regular distribution of lumens Uniform round lumens Irregular distribution of lumens Variable slit-like lumens Number of glands pattern they favor (Gleason pattern 3 or 4), and select from a list the criteria they used to make their choice (Table 1). Consensus was defined when at least 7/10 experts agreed on the grade. A pattern 3 or 4 was favored when 6/10 experts agreed on the grade. Equivocal answers were defined when 5/10 experts agreed/disagreed. RESULTS Diagnosis and Criteria Out of 36 static images sent to the panel of experts, 67% (n = 24) reached consensus of which 23 were Gleason pattern 4 (Figs. 1 7) and 1 was Gleason pattern 3 (Fig. 8). Of the 12 nonconsensus images, 7 were favor Gleason pattern 4 (Figs. 9 13), 1 was favor Gleason pattern 3 (Fig. 14), and 4 were equivocal (Figs. 15, 16). Three pathologists more commonly diagnosed cribriform pattern 3 and were responsible for 66% (67 out of 101) of the Gleason pattern 3 diagnoses (Table 2). Overall, Gleason pattern 4 was diagnosed 259 times out of 360 possibilities (72%). Between 23 consensus Gleason FIGURE 2. Consensus pattern 4 image (GP4:7, GP3:3). Irregular distribution of lumens (n = 4), irregular contour/ jagged edges (n = 4), variable slit-like lumens (n = 2), number of glands (n = 2), and small lumens (n = 1) were selected by the experts who diagnosed pattern 4. Small glands (n = 2), regular contour (n = 1), and regular distribution of lumens (n = 1) were selected by the experts who diagnosed pattern 3. pattern 4 images and 10 pathologists, there were a total of 190 Gleason pattern 4 diagnoses. Of these, the most common criteria used by the panel of experts to call pattern 4 were irregular contour (n = 122), irregular distribution of lumens (n = 92), slit-like lumens (n = 56), large glands (n = 51), number of glands (n = 45), and small lumens (n = 28). In the only consensus pattern 3 image, criteria were regular contour (n = 6), small glands FIGURE 1. Consensus pattern 4 image (GP4:8, GP3:2). Irregular distribution of lumens (n = 5), irregular contour/ jagged edges (n = 4), large glands (n = 2), and number of glands (n = 2) were selected by the experts who diagnosed pattern 4. Small glands (n = 2), regular contour (n = 2), and regular distribution of lumens (n = 1) were selected by the experts who diagnosed pattern 3. FIGURE 3. Consensus pattern 4 image (GP4:10, GP3:0). Irregular contour/jagged edges (n = 8), large glands (n = 4), irregular distribution of lumens (n = 4), number of glands (n = 3), variable slit-like lumens (n = 2), and small lumens (n = 1) were selected by the experts. r 2008 Lippincott Williams & Wilkins 1533

Latour et al Am J Surg Pathol Volume 32, Number 10, October 2008 FIGURE 4. Consensus pattern 4 image (GP4:10, GP3:0). Large glands (n = 6), irregular distribution of lumens (n = 4), variable slit-like lumens (n = 3), irregular contour/jagged edges (n = 2), small lumens (n = 1), and number of glands (n = 1) were selected by the experts. (n = 4), regular distribution of lumens (n = 3), and uniform round lumens (n = 2). Gleason Grade in Surrounding and Distant Cancer The highest grade in surrounding and distant cancer was noted for each 30 prostate needle biopsy cases selected for the study. Unequivocal Gleason pattern 4 FIGURE 6. Consensus pattern 4 image (GP4:9, GP3:1). Irregular contour/jagged edges (n = 8), number of glands (n = 6), irregular distribution of lumens (n = 4), variable slit-like lumens (n = 4), large glands (n = 3), and small lumens (n = 1) were selected by the experts who diagnosed pattern 4. Small glands and regular contour were selected by the only expert who diagnosed pattern 3. was seen in 73% (n = 22) of the cases. Of these, 3 cases showed one or more cores with Gleason score 8 and 19 cases showed 1 or more cores with Gleason score 7. In 8 needle biopsy cases, only Gleason pattern 3 was seen associated with the small cribriform foci in question. When submitted to the panel of experts, 3 of these cases with Gleason pattern 3 elsewhere ended up being FIGURE 5. Consensus pattern 4 image (GP4:7, GP3:3). Number of glands (n = 4), irregular contour/jagged edges (n = 3), irregular distribution of lumens (n = 2), variable slit-like lumens (n = 2), and small lumens (n = 1) were selected by the experts who diagnosed pattern 4. Regular contour (n = 3), small glands (n = 2), regular distribution of lumens (n = 2), and uniform round lumens (n = 1) were selected by the experts who diagnosed pattern 3. FIGURE 7. Consensus pattern 4 image (GP4:7, GP3:3). Irregular contour/jagged edges (n = 5), irregular distribution of lumens (n = 4), variable slit-like lumens (n = 2), number of glands (n = 1), and small lumens (n = 1) were selected by the experts who diagnosed pattern 4. Small glands (n = 3) and regular contour (n = 2) were selected by the experts who diagnosed pattern 3. 1534 r 2008 Lippincott Williams & Wilkins

Am J Surg Pathol Volume 32, Number 10, October 2008 Grading of Invasive Cribriform Carcinoma FIGURE 8. Consensus pattern 3 image (GP4:3, GP3:7). Regular contour (n = 6), small glands (n = 4), regular distribution of lumens (n = 3), and uniform round lumens (n = 2) were selected by the experts who diagnosed pattern 3. Irregular distribution of lumens (n = 1), number of glands (n = 1), and irregular contour/jagged edges (n = 1) were selected by the experts who diagnosed pattern 4. consensus Gleason pattern 4 (Figs. 1, 2), 3 ended up to be favor Gleason pattern 4 (Figs. 9 11), and 2 ended up to be equivocal (Figs. 15, 16). The only consensus Gleason pattern 3 image (Fig. 8) came from a needle biopsy case in which 2 other images were taken and interpreted as consensus Gleason pattern 4 (Fig. 2) and favor Gleason pattern 4. The only favor Gleason pattern 3 FIGURE 10. Favor pattern 4 image (GP4:6, GP3:4). Variable slit-like lumens (n = 4), irregular distribution of lumens (n = 3), irregular contour/jagged edges (n = 1), and small lumens (n = 1) were selected by the experts who diagnosed pattern 4. Regular contour (n = 3) and small glands (n = 2) were selected by the experts who diagnosed pattern 3. image (Fig. 14) came from a needle biopsy case that showed obvious Gleason pattern 4 elsewhere in the biopsy. Discrepancy Between Experts Out of 36 images of cribriform cancer sent, 26 ended up having at least 2 or more experts in disagreement with FIGURE 9. Favor pattern 4 image (GP4:6, GP3:4). Irregular contour/jagged edges (n = 3), irregular distribution of lumens (n = 2), variable slit-like lumens (n = 1), and number of glands (n = 1) were selected by the experts who diagnosed pattern 4. Regular contour (n = 3), small glands (n = 2), and regular distribution of lumens (n = 2) were selected by the experts who diagnosed pattern 3. FIGURE 11. Favor pattern 4 image (GP4:6, GP3:4). Irregular contour/jagged edges (n = 4), variable slit-like lumens (n = 2), number of glands (n = 2), and irregular distribution of lumens (n = 1) were selected by the experts who diagnosed pattern 4. Small glands (n = 3), regular contour (n = 2), and regular distribution of lumens (n = 2) were selected by the experts who diagnosed pattern 3. r 2008 Lippincott Williams & Wilkins 1535

Latour et al Am J Surg Pathol Volume 32, Number 10, October 2008 FIGURE 12. Favor pattern 4 image (GP4:6, GP3:4). Irregular distribution of lumens (n = 4), variable slit-like lumens (n = 4), small lumens (n = 1), and number of glands (n = 1) were selected by the experts who diagnosed pattern 4. Small glands (n = 4) and regular contour (n = 4) were selected by the experts who diagnosed pattern 3. the rest of the panel regarding the grade. Discrepancy between pathologists was qualified as primarily objective when different criteria were used by them (eg, regular contour vs irregular distribution of lumens seen with Figs. 12 and 16), subjective when there was a different interpretation of the same criteria (eg, regular contour vs irregular contour seen with Fig. 7), and mixed when it was FIGURE 14. Favor pattern 3 image (GP4:4, GP3:6). Regular contour (n = 5), small glands (n = 3) and regular distribution of lumens (n = 1) were selected by the experts who diagnosed pattern 3. Variable slit-like lumens (n = 4) and irregular distribution of lumens (n = 2) were selected by the experts who diagnosed pattern 4. both objective and subjective (seen with Figs. 5, 9, 11). Discrepancy between experts was objective in 38% (n = 10), subjective in 12% (n = 3), and mixed in 50% (n = 13). The most frequent criteria with objective discrepancy were small glands, regular contour, irregular distribution of lumens, and variable slit-like lumens. The most conflicting criteria observed in subjective and mixed FIGURE 13. Favor pattern 4 image (GP4:6, GP3:4). Irregular distribution of lumens (n = 3), large glands (n = 2), variable slitlike lumens (n = 2), small lumens (n = 1), and irregular contour/ jagged edges (n = 1) were selected by the experts who diagnosed pattern 4. Regular contour (n = 4), small gland (n = 1), regular distribution of lumens (n = 1), and uniform round lumens (n = 1) were selected by the experts who diagnosed pattern 3. FIGURE 15. Equivocal image (GP4:5, GP3:5). Regular contour (n = 3), small glands (n = 2), uniform round lumens (n = 1), and large lumens (n = 1) were selected by the experts who diagnosed pattern 3. Irregular distribution of lumens (n = 3), variable slit-like lumens (n = 2), small lumens (n = 1), and irregular contour/jagged edges (n = 1) were selected by the experts who diagnosed pattern 4. 1536 r 2008 Lippincott Williams & Wilkins

Am J Surg Pathol Volume 32, Number 10, October 2008 Grading of Invasive Cribriform Carcinoma FIGURE 16. Equivocal image (GP4:5, GP3:5). Small glands (n = 4), regular contour (n = 4), and regular distribution of lumens (n = 1) were selected by the experts who diagnosed pattern 3. Irregular distribution of lumens (n = 4), variable slitlike lumens (n = 3), small lumens (n = 1), and number of glands (n = 1) were selected by the experts who diagnosed pattern 4. discrepancy (n = 16) were regular versus irregular contour in 88% (n = 14) and small versus large glands in 31% (n = 5). DISCUSSION The diagnosis and grading of cribriform carcinoma of the prostate have been controversial since the introduction of the Gleason grading system in 1966. 9 According to the original drawing of D. F. Gleason, cribriform cancer was included in patterns 2, 3, 4, and 5, the latter being defined exclusively by the presence of comedonecrosis. 2,9,10 Current basal cell immunohistochemistry has introduced further complexity in the classification of cribriform lesions by highlighting new challenging entities like cribriform high-grade prostatic intraepithelial neoplasia and intraductal carcinoma of the prostate that would have fulfilled morphologic description of cribriform cancer. 1,3 5,11,15,18,19 In 2005, the Gleason grading system underwent its first major revision at an ISUP consensus conference. 6,8,12 One of the most important inputs from the consensus was the modification of the Gleason pattern 4 that now includes most cribriform patterns because there is an increased understanding that invasive cribriform carcinoma is a relatively aggressive disease. 17 More stringent criteria have been proposed to help pathologists separate the new cribriform Gleason pattern 3 from pattern 4, a distinction that would significantly impact on further therapeutic options and prognosis. 6,8 Cribriform Gleason pattern 3 is depicted as individual small round glands with regular contour and large round evenly spaced lumens opposed to Gleason pattern 4, which is characterized by larger glandular formations with irregular contour or jagged edges and/or TABLE 2. Frequency (%) of Gleason Patterns 3 and 4 Assigned by 10 Experts in Prostate Pathology to 36 Static Images of Small Foci of Cribriform Cancer Taken From 30 Prostate Needle Biopsy Cases No. 1 No. 2 No. 3 No. 4 No. 5 No. 6 No. 7 No. 8 No. 9 No. 10 Gleason pattern 4 78% (n = 28) 36% (n = 13) 33% (n = 12) 75% (n = 27) 92% (n = 33) 94% (n = 34) 89% (n = 32) 100% (n = 36) 44% (n = 16) 78% (n = 28) Gleason pattern 3 22% (n = 8) 64% (n = 23) 67% (n = 24) 25% (n = 9) 8% (n = 3) 6% (n = 2) 11% (n = 4) 0% (n = 0) 56% (n = 20) 22% (n = 8) r 2008 Lippincott Williams & Wilkins 1537

Latour et al Am J Surg Pathol Volume 32, Number 10, October 2008 smaller irregularly distributed lumens or slit-like lumens thought to be formed by the fusion of glands. The number of cribriform glands also seems to be a factor. Whereas, a single cribriform gland that fits the criteria for Gleason pattern 3 might be graded as pattern 3, some experts in the current study would diagnose pattern 4 in the setting of numerous such glands. Our results demonstrate a definite trend among experts in prostate pathology toward interpreting infiltrating cribriform carcinoma as Gleason pattern 4. In fact, most of the cribriform glands initially considered by Gleason to be pattern 3 before the new 2005 ISUP consensus classification are now reconsidered as pattern 4 or cribriform high-grade intraepithelial neoplasia by many authors. 8,13 These modifications with the others proposed in the modified Gleason grading system have been recently validated in different studies by showing a better correlation between needle biopsy grading and radical prostatectomy findings, and improved predictive accuracy in predicting biochemical disease-free survival after radical prostatectomy. 12,16 Even in our highly selected set of images thought to be the best morphologic candidates for cribriform pattern 3 cancer from a busy consult service, Gleason pattern 4 was either the consensus or favored diagnosis by a panel of experts in 30 images out of 36. Although cribriform Gleason pattern 3 was individually diagnosed by each expert, because of subjective and objective major discrepancies between them and the use of stringent criteria, a clear histomorphologic definition of what should be called cribriform pattern 3 was not achieved. Interestingly, the only image that was consensus cribriform Gleason pattern 3 originated from a case in which 2 other images were interpreted as consensus pattern 4 and favor pattern 4, which made the distinction between pattern 3 and 4 irrelevant in this situation. Moreover, the presence of coexistent obvious Gleason pattern 4 in the surrounding or distantcancerinupto73%ofourcasesquestionsthe biologic relevance and true existence of cribriform Gleason pattern 3. Martinez-Rodriguez et al 14 came to the same conclusions in a study of 32 cases of prostate cancer (65.6% on needle biopsy; 34.4% on radical prostatectomy), which had candidate cribriform Gleason pattern 3 cancer seen from 1/99 to 10/2005. With the original Gleason grading system, cribriform pattern 3 cancer was confirmed using immunohistochemistry in 22/32 cases. With the more strict 2005 ISUP classification system, only 6 cases were classified as cribriform Gleason pattern 3 cancer. All together, cribriform pattern 3 ranged between 8% and 15% of the total amount of the cribriform tumor glands, with the remaining being Gleason pattern 4. Glands with the appearance of cribriform pattern 3 on cut downs for immunohistochemistry were spatially in close proximity to cribriform pattern 4 and in some cases on serial sections cribriform pattern 3 glands started to show angulated contours of cribriform pattern 4. The authors concluded that cribriform pattern 3 was closely related to cribriform pattern 4 and that cribriform pattern 3 should be considered cribriform pattern 4. An analogous situation with cribriform Gleason pattern 3 is the grading of Gleason patterns 2 to 4 on needle biopsy. The recommendation of the Gleason consensus panel was The diagnosis of Gleason score 2 to 4 should rarely, if ever be made on needle biopsy. It does allow for the exceedingly rare case where low grade cancer has been sampled on needle biopsy. 8 With all the above caveats, for practical purposes, Gleason score 2 to 4 is not diagnosed on needle biopsy. Just as one requires the perfect yet unattainable low grade cancer to render a diagnosis of Gleason score 2 to 4 on biopsy, similarly the criteria for cribriform Gleason pattern 3 on biopsy is so stringent that for all intents and purposes, it is a diagnosis that will rarely, if ever be made. Of 3590 cases sent for consultation that formed the denominator in the current study (the vast majority Gleason score 6), the only 2 cases with either a consensus or favor Gleason pattern 3 came from needle biopsy cases in which there was obvious Gleason pattern 4 elsewhere in the biopsy. In conclusion, small cribriform cancer foci seen on needle biopsy should, with exceedingly rare exception, be interpreted as Gleason pattern 4 and not pattern 3. It has been difficult to characterize the clinical behavior of carcinomas with the cribriform patterns illustrated in this study because they are rarely found in a pure form. Future research that may address this issue would be to follow patients with this type of cribriform carcinoma and admixed noncribriform Gleason pattern 3 on biopsy to determine whether radical prostatectomy findings are more like a score of 6 or 7. However, the low numbers of these needle biopsy cases would require a multi-institutional study. REFERENCES 1. Amin MB, Schultz DS, Zarbo RJ. Analysis of cribriform morphology in prostatic neoplasia using antibody to high-molecular-weight cytokeratins. Arch Pathol Lab Med. 1994;118:260 264. 2. Bailar JC III, Mellinger GT, Gleason DF. Survival rates of patients with prostatic cancer, tumor stage, and differentiation preliminary report. Cancer Chemother Rep. 1966;50:129 136. 3. Bostwick DG, Amin MB, Dundore P, et al. Architectural patterns of high-grade prostatic intraepithelial neoplasia. Hum Pathol. 1993; 24:298 310. 4. Cohen RJ, McNeal JE, Baillie T. Patterns of differentiation and proliferation in intraductal carcinoma of the prostate: significance for cancer progression. Prostate. 2000;43:11 19. 5. Cohen RJ, Wheeler TM, Bonkhoff H, et al. A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma. Arch Pathol Lab Med. 2007;131:1103 1109. 6. Egevad L, Granfors T, Karlberg L, et al. Prognostic value of the Gleason score in prostate cancer. BJU Int. 2002;89:538 542. 7. Egevad L, Allsbrook WC Jr, Epstein JI. Current practice of Gleason grading among genitourinary pathologists. Hum Pathol. 2005;36: 5 9. 8. Epstein JI, Allsbrook WC Jr, Amin MB, et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005;29:1228 1242. 9. Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep. 1966;50:125 128. 10. Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol. 1974;111:58 64. 1538 r 2008 Lippincott Williams & Wilkins

Am J Surg Pathol Volume 32, Number 10, October 2008 Grading of Invasive Cribriform Carcinoma 11. Guo CC, Epstein JI. Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance. Mod Pathol. 2006;19:1528 1535. 12. Helpap B, Egevad L. The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens. Virchows Arch. 2006;449:622 627. 13. Lopez-Beltran A, Mikuz G, Luque RJ, et al. Current practice of Gleason grading of prostate carcinoma. Virchows Arch. 2006;448: 111 118. 14. Martinez-Rodriguez M, Ramos D, Mayordomo E, et al. Analysis of cribriform Gleason grade 3 in prostatic carcinoma. A histopathological and immunohistochemical study of 32 cases. Histopathology. 2007;51:717 719. 15. McNeal JE, Yemoto CE. Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations. Am J Surg Pathol. 1996;20:802 814. 16. Mitchell RE, Shah JB, Desai M, et al. Changes in prognostic significance and predictive accuracy of Gleason grading system throughout PSA era: impact of grade migration in prostate cancer. Urology. 2007;70:706 710. 17. Qian J, Jenkins RB, Bostwick DG. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization. Mod Pathol. 1997;10: 1113 1119. 18. Rubin MA, de La Taille A, Bagiella E, et al. Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications. Am J Surg Pathol. 1998;22: 840 848. 19. Wilcox G, Soh S, Chakraborty S, et al. Patterns of high-grade prostatic intraepithelial neoplasia associated with clinically aggressive prostate cancer. Hum Pathol. 1998;29:1119 1123. r 2008 Lippincott Williams & Wilkins 1539